Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee

2025/04/09 by Guillermo Ortí, Guillaume Dachy, Charlotte E. Graham +23 · 1 voice
Immunology and Microbiology · Medicine · #Autoimmune and Inflammatory Disorders Research #CAR-T cell therapy research #Immune Cell Function and Interaction

paper · doi:10.1038/s41409-025-02567-5

openalex publication_date 2025/04/09 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Citations

• Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
• Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities
• Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

Discussions

• Less frequent complications following CAR T-cell: HLH, GVHD, TMA, coag disorders and 2nd malignancies: recommendations from the EBMT Practice Harmonization and Guidelines Committee Bone Marrow Transp [bsky, 0 points, 0 comments]